Search
for
Sort by
Research 511–540 of 1000+
- Sensitive bromatometric assay methods for finasteride in pharmaceuticals
- New lifestyle drugs and somatoform disorders in dermatology
- Small molecules and small molecule drugs in regenerative medicine
- Semaglutide-Induced Atypical Pustular Drug Eruption: A Case Report
- Grand challenges in dermatologic drug discovery: four priorities to transform skin disease treatment
- FORMULATION AND EVALUATION OF MINOXIDIL GEL IN COMBINATION WITH ALOE VERA FOR TOPICAL APPLICATION FOR THE TREATMENT OF ALOPECIA
- Microneedles as the technique of drug delivery enhancement in diverse organs and tissues
- Recent progress in PLGA-based microneedle-mediated transdermal drug and vaccine delivery
- Postmarketing Surveillance of New Antiepileptic Drugs: The Tribulations of Trials
- Oil Body-Bound Oleosin-rhFGF-10: A Novel Drug Delivery System that Improves Skin Penetration to Accelerate Wound Healing and Hair Growth in Mice
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- Medication Repurposing: New Uses for Old Drugs
- A Review on Herbal Drugs Used For Hair Growth Promotion
- ANALYSIS OF ADVERSE DRUG REACTIONS (ADRs) AND THEIR SEVERITY IN BREAST CANCER PATIENTS TREATED WITH THE DOCETAXEL-DOXORUBICIN REGIMEN AT SULTAN AGUNG ISLAMIC HOSPITAL
- Repurposing FDA approved drugs for psoriasis indications through integrated molecular docking, one-SVM algorithm, and molecular dynamics simulation approaches
- Integrating herbal components into pharmaceutical formulations for hair woes
- Nutraceutical : An emerging Pharmaceutical Towards Prevention Of Diseases
- Optimal concentration selection of active pharmaceutical ingredients in the cream-mask intended for androgenic alopecia treatment according to experimental results on paramecium caudatum biological model
- Toxicity of the pharmaceuticals finasteride and melengestrol acetate to benthic invertebrates
- Psychotropic Medication and Drug-Related Alopecia
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III
- Development of Stratum Corneum Lipid Liposomes for Topical Drug Delivery
- NUMERICAL DESCRIPTOR COMPUTATION OF ALOPECIA DRUGS USING COM – POLYNOMIAL
- Spironolactone and XPB: An Old Drug with a New Molecular Target
- Lysocellin, a metabolite of the novel drug ‘alopestatin’, induces G1 arrest and prevents cytotoxicity induced by etoposide
- Natural products and their derivatives as candidate treatments for hair greying: from drug discovery to molecular mechanisms
- Modeling the pharmacodynamics of nandrolone doping drug and implications for anti‐doping testing
- Alternative treatment of polycystic ovary syndrome: pre-clinical and clinical basis for using plant-based drugs
- Quantitative Determination of α-Tocopherol and α-Tocopheryl Acetate in Pharmaceutical and Supplementary Soft Capsules by High Performance Liquid Chromatography
- Microgel emulsion loaded with recombinant oil body as a new drug delivery carrier to promote wound repair